The sooner allodynia is identified, the more options are available for management, and the less likely central sensitization is to become deeply established
Determination of P
Administered as a once-weekly subcutaneous injection with gradual dose titration
Among commercially insured non-diabetic individuals with obesity, people who identified as female, received point-of-service or preferred provider organization insurance coverage, and who took medications such as antidepressants or thyroid or hormone medications, were more likely to begin taking semaglutide compared to people who identified as males, or those who were covered by health management organization or exclusive provider organization plans
No heterogeneity was presented in the included studies (I 2 = 0%, P = 0.78), and we used the fixed effects model (Fig
However, eligibility varies, and private treatment is often a faster alternative